Recent studies demonstrated that elevated PD-1 expression on specific CTL directed against CML cells is related to loss of CTL lytic activity after co-stimulation with PD-L1-positive CML cells [138]. The gene discussed is CD274; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.